- Category: Business
Business
Smartlens raises $5.2 million to advance miLens FDA clearance and launch
Financing to support the ongoing advancement and FDA clearance process of the miLens, an electronics-free contact lens technology.
Business
Lilly to purchase Adverum Biotechnologies
With a Q4 closing date in mind, acquisition supports ongoing clinical trials and development activities for Ixo-vec, a one-time IVT gene therapy injection to treat wet AMD.
Business
Ciliatech to open US subsidiary supporting clinical advancement of novel glaucoma device
Upcoming clinical trials to study the Intercil Uveal Spacer, a cilioscleral interpositioning device that reestablishes the natural uveoscleral outflow.
Business
Topcon invests in Sanro Health
Latest strategic investment involves the Sanro Optimizer, which integrates EMR and imaging data to rapidly identify eligible participants for clinical trials.
Business
Leadership update: ImprimisRx gets new CEO, BioTissue forms MAB
Leadership changes are underway in the eyecare space—and we’ve got the latest.
Business
EssilorLuxottica purchases RetinAI
Ikarian subsidiary is the developer of the FDA-cleared Discovery platform, an AI-based imaging data management system for diagnosing and monitoring ophthalmic disease progression.
Business
Topcon officially debuts the Institute for Digital Health
Oculomics company features an AI-based analytics platform designed to provide fast and secure access to real-world and clinical trial datasets.
Business
Topcon purchases Toku, Inc
Acquisition supports ongoing Healthcare from the Eye initiative with a portfolio of AI-based diagnostic and retinal imaging technology.
Business
Leadership watch: KALA BIO names new CEO, Aurion Biotech promotes execs
Aurion makes its move ahead of initiating a phase 3 trial in early 2026 for its allogeneic cell therapy, under evaluation for corneal endothelial disease.
Business
Verséa Ophthalmics relaunches as DefEYE Inc
Ophthalmic biologics company makes official debut with the exclusive U.S. commercial rights to the BIOVANCE franchise of decellularized biologics.
Business
Harrow to purchase Melt Pharmaceuticals
Key draw is the company’s patented oral tablet formulated for a sublingual delivery to provide rapid sedation and analgesia ahead of cataract surgery.
Business
Leadership watch: SpyGlass, Lumata Health, and Horizon Surgical report changes
Latest news from the eyecare space includes a new VP at SpyGlass ahead of phase 3 trials on its glaucoma drug delivery platform.
Business
Ollin Biosciences debuts with next-gen ophthalmic pipeline
Biotech launches with $100 million financing and a lead program addressing wet AMD and DME via a higher potency VEGF/Ang2 bispecific antibody.
Business
EyeMD EMR rebrands as Optivate with expanded vision
Clinical software solutions company initiates months-long transition in its ophthalmology practice services, with completion date set for end of 2025.
Business
Eyexora launches with focus on accelerated ophthalmic asset development
First ‘hub-and-spoke’ model ophthalmology company is targeting a global portfolio of anterior and posterior segment therapeutics and medical devi
Business
Leadership watch: Haag-Stret, Heidelberg, and Samsara name new executives
Check out the latest leadership news from the eyecare space, including a new CEO at Haag-Streit and other major appointments.
Business
Neurolens debuts official rebrand as Newton
Maker of the first and only therapeutic lenses clinically proven to relieve eye misalignment symptoms announces next chapter in its eyecare journey.
Business
Topcon invests in Senseye's ocular biomarker-based mental health platform
First app of its kind utilizes the eye as a non-invasive window to the brain to identify neuropsychiatric conditions—in just 15 minutes.
Business
OpZira launches with LumiThera diagnostic product line
Spin-off company official forms following Alcon-LumiThera acquisition to offer two ophthalmic products: the AdaptDx Pro and NOVA Vision Testing System.
Business